(Incorporated in the Cayman Islands)

We are a newly organized blank check company. We intend to focus on the technology sector in our search for a target company. We expect to look at companies involved in areas such as harm reduction, wellness products, hemp-derived consumables, psychedelics, health-oriented markets and tech-enabled platforms.

Michael Cam-Phung is the chairman of Cambridge Acquisiton. He is the VP and head of medtech solutions strategy at Tekni-Plex.

Brent Cox is the CEO and a director. He is the founder and managing principal of private investment firm Subtext Holdings.

Anthony Naimo is our CFO. He is the managing director of Procorso, a management consulting firm, and the CFO of Sarah Flint.

(Note: Cambridge Acquisition priced its SPAC IPO in sync with the terms in the prospectus – 20 million units at $10.00 each – and raised $200 million on Thursday night, Feb. 5, 2026. Each unit consists of one share of  stock and one-third of one warrant. Background: Cambridge Acquisition disclosed the terms for its SPAC IPO in an S-1 filing on Dec. 15, 2025.)